name: Aflibercept Time-Based T&E (8-week minimum) Copy
version: 1.0.1
created_date: '2025-06-23'
author: Your Name
description: Copy of Aflibercept Time-Based T&E (8-week minimum)
model_type: time_based
transition_model: fortnightly
update_interval_days: 14
protocol_type: treat_and_extend
loading_dose_injections: 3
loading_dose_interval_days: 28
min_interval_days: 56
max_interval_days: 112
extension_days: 14
shortening_days: 14
disease_transitions_file: parameters/disease_transitions.yaml
treatment_effect_file: parameters/treatment_effect.yaml
vision_parameters_file: parameters/vision.yaml
discontinuation_parameters_file: parameters/discontinuation.yaml
demographics_parameters_file: parameters/demographics.yaml
baseline_vision_distribution:
  type: beta_with_threshold
  alpha: 3.5
  beta: 2.0
  min: 5
  max: 98
  threshold: 70
  threshold_reduction: 0.6
clinical_improvements:
  enabled: true
  use_loading_phase: true
  use_time_based_discontinuation: true
  use_response_based_vision: true
  use_baseline_distribution: false
  use_response_heterogeneity: true
  response_types:
    good:
      probability: 0.6
      multiplier: 1.8
    average:
      probability: 0.3
      multiplier: 1.0
    poor:
      probability: 0.1
      multiplier: 0.5
  discontinuation_probabilities:
    1: 0.1
    2: 0.15
    3: 0.12
    4: 0.08
    5: 0.075
  vision_response_params:
    loading:
      mean: 4.0
      std: 1.5
    year1:
      mean: 1.0
      std: 1.0
    year2:
      mean: 0.0
      std: 1.0
    year3plus:
      mean: -0.3
      std: 1.0
target_outcomes:
  year1:
    mean_bcva_change: 6.0
    mean_injections: 7.5
  year2:
    mean_bcva_change: 5.0
    cumulative_injections: 12.5
